You are viewing an inactive listing

Burlington, Vermont 05401

  • Related Disorders

Purpose:

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.


Criteria:

Please contact site for information.


NCT ID:

NCT00000240


Primary Contact:

Principal Investigator
Warren Bickel, Ph.D.
University of Vermont


Backup Contact:

N/A


Location Contact:

Burlington, Vermont 05401
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.